At a glance
ClinicalIndex Comparison RecordN/ACompleted· 188 enrolled
Drug / intervention
Medtronic Implantable Tibial Neuromodulation (TNM) Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Implantable Tibial Neuromodulation Pivotal Study
In Brief
A clinical study evaluating Medtronic Implantable Tibial Neuromodulation (TNM) System for Overactive Bladder. Completed, enrolled 188 participants across 29 sites.
Detailed Summary
The purpose of this prospective, multicenter study is to assess the safety and efficacy of tibial neuromodulation using the Medtronic Tibial Neuromodulation (TNM) system.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOveractive Bladder
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJan 2022
First PostedFeb 2022
Primary CompletionOct 2023
Study CompletionMay 2025
TodayJul 2026
First PostedFeb 7, 2022
Enrollment StartJan 31, 2022
Primary CompletionOct 10, 2023
Study CompletionMay 30, 2025
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 4.4 years ago
Interventions
Medtronic Implantable Tibial Neuromodulation (TNM) Systemdevice
Stimulation of the tibial nerve using Medtronic's tibial neuromodulation device.